Abstract
TUMOUR-promoting phorbol esters have contributed to the concept of multiple-step carcinogenesis1, as illustrated in the two-stage mouse skin carcinogenesis model2. Promoters are not significantly carcinogenic when tested alone, but decrease the threshold dose of carcinogens (initiators) and reduce the latency period for tumour appearance. 12-O-tetradecanoyl-phorbol-13-acetate (TPA) and several other diterpene esters represent potent tumour promoters3–5. Recently, it has been shown that these promoters efficiently induce persisting genomes of oncogenic herpesviruses, particularly of Epstein–Barr virus (EBV)6–8, resulting in high percentages of viral antigen and particle-positive cells. Other observations showed that TPA enhances in vitro transformation of fibroblasts previously exposed to polycyclic aromatic hydrocarbons, UV light or adenoviruses9–12. These studies prompted us to analyse the effect of TPA not only on virus induction in EBV genome-harbouring cells, but also on EBV-induced transformation of human cord blood lymphocytes. Our data show that low concentrations of TPA significantly enhance transformation of lymphocytes by EBV.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Foulds, L. Neoplastic Development (Academic, New York, 1969).
Berenblum, I. in Cancer Vol. 1 (ed. Becker, F. F.) 323–344 (Plenum, New York, 1975).
Van Duuren, B. L. Prog. exp. Tumor Res. 11, 31–68 (1969).
Boutwell, R. K. CRC crit. Rev. Tox. 2, 419–443 (1974).
Hecker, E. in Handbuch der Allgemeinen Pathologie, Vol. 4 (ed. Grundmann, E.) 651–675 (Springer, Berlin, 1975).
zur Hausen, H., O-Neill, F. J., Freese, U. K. & Hecker, E. Nature 272, 373–375 (1978).
zur Hausen, H., Bornkamm, G. W., Schmidt, R. & Hecker, E. Proc. natn. Acad. Sci. U.S.A. 76, 782–785 (1979).
Yamamoto, N., Bister, K. & zur Hausen, H. Nature 278, 553–554 (1979).
Lasne, C., Gentil, A. & Chouroulinkov, I. Nature 247, 490–491 (1974).
Mondal, S., Brankow, D. W. & Heidelberger, C. Cancer Res. 36, 2254–2260 (1976).
Mondal, S. & Heidelberger, C. Nature 260, 710–711 (1976).
Fisher, P. B., Weinstein, B., Eisenberg, D. & Ginsberg, H. S. Proc. natn. Acad. Sci. U.S.A. 75, 2311–2314 (1978).
Miller, G. & Lipmann, M. Proc. natn. Acad. Sci. U.S.A. 70, 190–194 (1973).
Yamamoto, N. & Hinuma, Y. Int. J. Cancer 17, 191–196 (1976).
Katsuki, T., Hinuma, Y., Yamamoto, N., Abo, T. & Kumagai, K. Virology 83, 287–294 (1977).
Yamamoto, N. & Hinuma, Y. Virology 89, 623–626 (1978).
Touraine, J. L. et al. J. exp. Med. 145, 460–465 (1977).
Bister, K., Yamamoto, N. & zur Hausen, H. Int. J. Cancer 23, 818–825 (1979).
Macpherson, I. in Tissue Cultures (eds Kruse, P. F. & Patterson, M. K.) Ch. 7 (Academic,New York, 1973).
Böyum, A. Scand. J. chim. Invest. 21, Suppl. 97, 77–89 (1968).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
YAMAMOTO, N., HAUSEN, H. Tumour promoter TPA enhances transformation of human leukocytes by Epstein–Barr virus. Nature 280, 244–245 (1979). https://doi.org/10.1038/280244a0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/280244a0
This article is cited by
-
Cell proliferation-associated expression of a recently evolved isozyme of triosephosphate isomerase
Biochemical Genetics (1985)
-
Host defense mechanisms against tumors as the principal targets of tumor promoters
Journal of Cancer Research and Clinical Oncology (1983)
-
Unique cell lines harbouring both Epstein–Barr virus and adult T-cell leukaemia virus, established from leukaemia patients
Nature (1982)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.